Latest & greatest articles for adhd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

ADHD

ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:

  • inattentiveness
  • hyperactivity and impulsiveness

Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).

Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).

Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.

Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).

Top results for adhd

121. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day

Duration of effect of oral long-acting stimulant medications for ADHD throughout the day Duration of effect of oral long-acting stimulant medications for ADHD throughout the day Duration of effect of oral long-acting stimulant medications for ADHD throughout the day Brams M, Moon E, Pucci M, Lopez FA CRD summary This review found that most long-acting stimulants conferred benefits in populations with attention-deficit/hyperactivity disorder for up to 12 hours as measured by mathematics tests (...) . Methodological flaws and a lack of information about the quality of the studies mean that the results should be interpreted with some caution and made the reliability of the authors' conclusions unclear. Authors' objectives To determine the duration of effect of long-acting stimulant treatment in patients with attention-deficit hyperactivity disorder (ADHD) using analogue classroom protocols. Searching MEDLINE, BIOSYS and EMBASE were searched to June 2009 for relevant published studies; search terms were

2010 DARE.

122. Children with ADHD at increased risk of adolescent ADHD, ODD, anxiety or depression and functional impairment

Children with ADHD at increased risk of adolescent ADHD, ODD, anxiety or depression and functional impairment Children with ADHD at increased risk of adolescent ADHD, ODD, anxiety or depression and functional impairment | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Children with ADHD at increased risk of adolescent ADHD, ODD, anxiety or depression and functional impairment Article Text Prognosis Children with ADHD at increased

2010 Evidence-Based Mental Health

123. Early school-based screening and intervention programmes for ADHD did not improve children's outcomes at age 10

Early school-based screening and intervention programmes for ADHD did not improve children's outcomes at age 10 Early school-based screening and intervention programmes for ADHD did not improve children's outcomes at age 10 | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Early school-based screening and intervention programmes for ADHD did not improve children's outcomes at age 10 Article Text Therapeutics Early school-based screening

2010 Evidence-Based Mental Health

124. Review: ADHD impairs quality of life, but children and young people with ADHD perceive less impairment than parents

Review: ADHD impairs quality of life, but children and young people with ADHD perceive less impairment than parents Review: ADHD impairs quality of life, but children and young people with ADHD perceive less impairment than parents | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: ADHD impairs quality of life, but children and young people with ADHD perceive less impairment than parents Article Text Prognosis Review: ADHD

2010 Evidence-Based Mental Health

125. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

126. CPG on Attention Deficit Hyperactivity Disorder (ADHD) in the Child and Adolescent Population

CPG on Attention Deficit Hyperactivity Disorder (ADHD) in the Child and Adolescent Population Clinical Practice Guideline on Attention De? cit Hyperactivity Disorder (ADHD) in Children and Adolescents CLINICAL PRACTICE GUIDELINES IN THE SPANISH NATIONAL HEALTHCARE SYSTEM MINISTRY OF HEALTH, SOCIAL POLICY , AND EQUALITY MINISTERIO DE SANIDAD, POLÍTICA SOCIAL E IGUALDADIt has been 5 years since the publication of this Clinical Practice Guideline and it is subject to updating. Clinical Practice (...) Guideline on Attention De? cit Hyperactivity Disorder (ADHD) in Children and Adolescents CLINICAL PRACTICE GUIDELINES IN THE SPANISH NHS MINISTRY OF HEALTH AND SOCIAL POLICIES MINISTERIO DE SANIDAD, POLÍTICA SOCIAL E IGUALDAD It has been 5 years since the publication of this Clinical Practice Guideline and it is subject to updating. This CPG is a healthcare decision aid. It is not mandatory and it is not a substitute for the clinical judgement of healthcare personnel. Version: 2010 Published

2010 GuiaSalud

127. Evaluating dopamine reward pathway in ADHD: clinical implications. (PubMed)

Evaluating dopamine reward pathway in ADHD: clinical implications. Attention-deficit/hyperactivity disorder (ADHD)--characterized by symptoms of inattention and hyperactivity-impulsivity--is the most prevalent childhood psychiatric disorder that frequently persists into adulthood, and there is increasing evidence of reward-motivation deficits in this disorder.To evaluate biological bases that might underlie a reward/motivation deficit by imaging key components of the brain dopamine reward (...) pathway (mesoaccumbens).We used positron emission tomography to measure dopamine synaptic markers (transporters and D(2)/D(3) receptors) in 53 nonmedicated adults with ADHD and 44 healthy controls between 2001-2009 at Brookhaven National Laboratory.We measured specific binding of positron emission tomographic radioligands for dopamine transporters (DAT) using [(11)C]cocaine and for D(2)/D(3) receptors using [(11)C]raclopride, quantified as binding potential (distribution volume ratio -1).For both

Full Text available with Trip Pro

2009 JAMA

128. Stimulants for Attention-Deficit/Hyperactivity Disorder (ADHD) in children

Stimulants for Attention-Deficit/Hyperactivity Disorder (ADHD) in children Stimulants for Attention-Deficit/Hyperactivity Disorder (ADHD) in children Stimulants for Attention-Deficit/Hyperactivity Disorder (ADHD) in children Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Report may be purchased from . Citation Stimulants for Attention-Deficit/Hyperactivity Disorder (...) (ADHD) in children . Lansdale: HAYES, Inc.. 2009 Authors' objectives Attention-deficit hyperactivity disorder (ADHD) is a common disorder of childhood and adolescence that is characterized by symptoms of inattention and/or hyperactivity/impulsivity with symptoms persisting for at least 6 months and to an extent that is maladaptive and inconsistent with developmental level. Stimulant medications are widely used for the treatment of ADHD in children and adults. Project page URL Indexing Status Subject

2009 Health Technology Assessment (HTA) Database.

129. Nonpharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children:Behavior Therapy

Nonpharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children:Behavior Therapy Nonpharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children:Behavior Therapy Nonpharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children:Behavior Therapy Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA (...) database. Report may be purchased from . Citation Nonpharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children:Behavior Therapy . Lansdale: HAYES, Inc.. 2009 Authors' objectives Behavior therapy (BT) for attention-deficit hyperactivity disorder (ADHD) was developed as a way to increase desirable behaviors and reduce or eliminate the undesirable behaviors and tendencies associated with ADHD, including disruptive behavior, poor social skills, poor academic performance

2009 Health Technology Assessment (HTA) Database.

130. Nonpharmacological treatments for attention-deficit/hyperactivity disorder (ADHD): Neurofeedback

Nonpharmacological treatments for attention-deficit/hyperactivity disorder (ADHD): Neurofeedback Nonpharmacological treatments for attention-deficit/hyperactivity disorder (ADHD): Neurofeedback Nonpharmacological treatments for attention-deficit/hyperactivity disorder (ADHD): Neurofeedback Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Report may be purchased from (...) . Citation Nonpharmacological treatments for attention-deficit/hyperactivity disorder (ADHD): Neurofeedback . Lansdale: HAYES, Inc.. 2009 Authors' objectives Neurofeedback for attention-deficit/hyperactivity disorder (ADHD) is used to teach patients to regulate brain activity that appears impaired in ADHD. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Diets Language Published English Country of organisation United

2009 Health Technology Assessment (HTA) Database.

131. Review: prevalence of adult ADHD declines with age

Review: prevalence of adult ADHD declines with age Review: prevalence of adult ADHD declines with age | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password (...) ? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: prevalence of adult ADHD declines with age Article Text Prevalence Review: prevalence of adult ADHD declines with age Statistics from Altmetric.com Question Question: What is the prevalence of adult attention deficit hyperactivity disorder (ADHD) and which factors have

2009 Evidence-Based Mental Health

132. Atomoxetine for ADHD in Children and Adolescents

Atomoxetine for ADHD in Children and Adolescents [73] Atomoxetine for ADHD in Children and Adolescents | Therapeutics Initiative Independent Healthcare Evidence > > [73] Atomoxetine for ADHD in Children and Adolescents In Letter #69 we summarized the evidence for the CNS stimulants, methylphenidate, dextroamphetamine and mixed amphetamine salts, to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and concluded “Better benefit and harm evidence is necessary before long-term CNS (...) stimulant treatment can be recommended.” That Letter did not assess atomoxetine (Strattera®) the newest drug indicated for treatment of ADHD. The rate of prescribing of atomoxetine in British Columbia (BC) in 2008 and 2009 is similar to mixed amphetamine salts (Adderall®), about one third of dextroamphetamine (Dexedrine®) and about one sixth of methylphenidate (Ritalin®, Concerta®). Approved indications: ADHD in children aged 6 or older, adolescents, and adults. Mechanism of action: Atomoxetine

2009 Therapeutics Letter

133. Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK

Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK Prasad S, Arellano J, Steer C, Libretto SE Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) Health Service. The methodology was valid, but most of the details of the methods and results were published in another paper. The authors’ conclusions appear to be robust. Type of economic evaluation Cost-utility analysis Study objective This study was an economic evaluation of atomoxetine for children with attention deficit and hyperactivity disorder (ADHD) compared with alternative treatments, such as psychostimulants, in various subgroups of patients depending on their previous treatment history

Full Text available with Trip Pro

2009 NHS Economic Evaluation Database.

134. Osmotically released methylphenidate is more effective than atomoxetine in children and adolescents with ADHD

Osmotically released methylphenidate is more effective than atomoxetine in children and adolescents with ADHD Osmotically released methylphenidate is more effective than atomoxetine in children and adolescents with ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Osmotically released methylphenidate is more effective than atomoxetine in children and adolescents with ADHD Article Text Therapeutics Osmotically released

2009 Evidence-Based Mental Health

135. Review: Methylphenidate and psychosocial treatments either alone or in combination reduce ADHD symptoms

Review: Methylphenidate and psychosocial treatments either alone or in combination reduce ADHD symptoms Review: Methylphenidate and psychosocial treatments either alone or in combination reduce ADHD symptoms | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: Methylphenidate and psychosocial treatments either alone or in combination reduce ADHD symptoms Article Text Therapeutics Review: Methylphenidate and psychosocial

2009 Evidence-Based Mental Health

136. Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD

Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using (...) your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD Article Text

2008 Evidence-Based Mental Health

137. Maternal adiposity prior to pregnancy is associated with ADHD symptoms in offspring: evidence from three prospective pregnancy cohorts (PubMed)

Maternal adiposity prior to pregnancy is associated with ADHD symptoms in offspring: evidence from three prospective pregnancy cohorts We examine whether pregnancy weight (pre-pregnancy body mass index (BMI) and/or weight gain) is related to core symptoms of attention deficit hyperactivity disorder (ADHD) in school-age offspring.Follow-up of prospective pregnancy cohorts from Sweden, Denmark and Finland within the Nordic Network on ADHD.Maternal pregnancy and delivery data were collected (...) prospectively. Teachers rated inattention and hyperactivity symptoms in offspring. High scores were defined as at least one core symptom rated as 'severe' and two as 'present' (approximately 10% of children scored in this range). Logistic regression and latent class analyses were used to examine maternal pregnancy weight in relation to children's ADHD core symptoms.Teacher rated 12 556 school-aged children. Gestational weight gain outside of the Institute of Medicine guidelines was not related to ADHD

Full Text available with Trip Pro

2008 EvidenceUpdates

138. Treatment of adult ADHD: Is current knowledge useful to clinicians?

Treatment of adult ADHD: Is current knowledge useful to clinicians? Treatment of adult ADHD: Is current knowledge useful to clinicians? Treatment of adult ADHD: Is current knowledge useful to clinicians? Torgersen T, Gjervan B, Rasmussen K CRD summary This review concluded there was good support for the pharmacological and psychotherapeutic treatment of attention deficit hyperactivity disorder in adults. It is likely that the review was affected by multiple sources of error and bias, which (...) means that the conclusions should not be regarded as reliable. Authors' objectives To review the literature on pharmacological and psychotherapeutic treatment for adult attention deficit hyperactivity disorder (ADHD) with a particular emphasis on comorbidity. Searching The following databases were searched to January 2007 and search terms were not reported: PubMed, EMBASE, PsycINFO and the Cochrane Library. References from included studies were also searched for relevant papers. Study selection

2008 DARE.

139. Collaborative consultation increases use of medication titration trials but not behaviour in children with ADHD

Collaborative consultation increases use of medication titration trials but not behaviour in children with ADHD Collaborative consultation increases use of medication titration trials but not behaviour in children with ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Collaborative consultation increases use of medication titration trials but not behaviour in children with ADHD Article Text Therapeutics Collaborative consultation

2008 Evidence-Based Mental Health

140. [Treatment of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults with central stimulants]

[Treatment of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults with central stimulants] Behandling av ADHD (Attention-deficit/hyperactivity disorder) hos vuxna, med centralstimulerande medel [Treatment of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults with central stimulants] Behandling av ADHD (Attention-deficit/hyperactivity disorder) hos vuxna, med centralstimulerande medel [Treatment of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults with central stimulants (...) ] The Regional Health Technology Assessment Centre (HTA-centrum) Citation The Regional Health Technology Assessment Centre (HTA-centrum). Behandling av ADHD (Attention-deficit/hyperactivity disorder) hos vuxna, med centralstimulerande medel. [Treatment of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults with central stimulants] Gothenburg: The Regional Health Technology Assessment Centre (HTA-centrum). HTA-rapport 2008:10. 2008 Authors' objectives Are ADHD symptoms positively affected, in adult

2008 Health Technology Assessment (HTA) Database.